Isolated Tricuspid Valve Libman-sacks Endocarditis in Patient with Systemic Lupus Erythematosus: A Rare Case Report and Literatures Review
Published: 2023-09-15
Page: 116-119
Issue: 2023 - Volume 5 [Issue 1]
H. Charif *
Department of Cardiology, Ibn Rochd University Hospital, Casablanca, Morocco.
M. Haboub
Department of Cardiology, Ibn Rochd University Hospital, Casablanca, Morocco and Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco.
S. Arous
Department of Cardiology, Ibn Rochd University Hospital, Casablanca, Morocco and Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco.
Med G. Benouna
Department of Cardiology, Ibn Rochd University Hospital, Casablanca, Morocco and Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco.
A. Drighil
Department of Cardiology, Ibn Rochd University Hospital, Casablanca, Morocco and Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco.
L. Azzouzi
Department of Cardiology, Ibn Rochd University Hospital, Casablanca, Morocco and Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco.
R. Habbal
Department of Cardiology, Ibn Rochd University Hospital, Casablanca, Morocco and Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Libman-Sacks endocarditis (LSE), characterized by the formation of verrucous vegetations, is a typical cardiac manifestation of autoimmune diseases such as systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). It primarily leads to cardiac valve lesions. The most commonly affected valves in systemic lupus erythematosus are the mitral and aortic valves. Although isolated tricuspid valve involvement is quite rare. Here, we report the case of a 38-year old female with a history of SLE who suffered from acute right heart failure caused by tricuspid vegetation and valve regurgitation. The patient was successfully treated with prednisolone and hydroxychloroquine, and follow-up echocardiography showed the disappearance of the vegetations.
Keywords: Tricuspid valve, Libman-Sacks endocarditis, systemic lupus erythematosus
How to Cite
Downloads
References
Kong TQ, Kellum RE, Haserick JR. Clinical diagnosis of cardiac involvement in systemic lupus erythematosus. Circulation 1962;26:7–11.
Moaref AR, Afifi S, Rezaian S, Rezaian GR. Isolated tricuspid valve Libman-Sacks endocarditis and valvular stenosis: unusual manifestations of systemic lupus erythematosus. J Am Soc Echocardiogr. 2010;23(3):341.3–5.
Chappuis S. Atteintes cardiaques dans les connectivites: l'exemple du lupus érythémateux systémique. Revue Médicale Suisse. 2010;6(245):804,806–11.
Bai Z, Hou J, Ren W, Guo Y. Diagnosis and surgical treatment for isolated tricuspid libman-sacks endocarditis: a rare case report and literatures review. Journal of Cardiothoracic Surgery. 2015;10(1):1-6.
Ziporen L, Goldberg I, Arad M, et al. Libman-sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus. 1996;5(3):196–205.
Feigenbaum HAW, Ryan T. Feigenbaum’s Echocardiography. Philadelphia: Lippincott Williams and Wilkins; 2005.
Plastiras SC, Pamboucas CA, Tektonidou M, Toumanidis ST. Real-time three-dimensional echocardiography in evaluating libman-sacks vegetations. Eur J Echocardiogr. 2010;11(2):184–5.
Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (libman-sacks endocarditis) in the antiphospholipid syndrome. Circulation. 1996;93(8): 1579–87.
Morin AM, Boyer AS, Nataf P, Gandjbakhch I. Mitral insufficiency caused by systemic lupus erythematosus requiring valve replacement: three case reports and a review of the literature. Thorac Cardiovasc Surg. 1996;44(6):313–6.
Hoffman R, Lethen H, Zunker U, Schondube FA, Maurin N, Sieberth HG. Rapid appearance of severe mitral regurgitation under high-dosage corticosteroid therapy in a patient with systemic lupus erythematosus. Eur Heart J. 1994;15(1):138–9.
Moaref AR, Afifi S, Rezaian S, Rezaian GR. Isolated tricuspid valve libman-sacks endocarditis and valvular stenosis: unusual manifestations of systemic lupus erythematosus. J Am Soc Echocardiogr. 2010;23(3):341:343-345.
Gonzalez-Juanatey C, Gonzalez-Gay MA. Libman-sacks endocarditis and primary antiphospholipid syndrome. J Heart Valve Dis. 2005;14(5):700–2.
McMurray JJ, Adamopoulos S, Anker SD, et al. Esc guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the heart failure association (hfa) of the esc. Eur Heart J. 2012;33(14): 1787–847.
Gordon RJ, Weilbaecher D, Davy SM, et al. Valvulitis involving a bioprosthetic valve in a patient with systemic lupus erythematosus. J Am Soc Echocardiogr. 1996;9(1):104–7.
da Silva AN, Ferreira LD, Monaco CG, et al. Intracardiac thrombosis and mitral prosthesis dysfunction in systemic lupus erythematosus. A case report. Rev Port Cardiol. 2003;22(2):213–9.
Said SM, Burkhart HM, Schaff HV, Johnson JN, Connolly HM, Dearani JA. When should a mechanical tricuspid valve replacement be considered? J Thorac Cardiovasc Surg. 2014;148(2): 603–8.
Hwang HY, Kim KH, Kim KB, Ahn H. Mechanical tricuspid valve replacement is not superior in patients younger than 65 years who need long-term anticoagulation. Ann Thorac Surg. 2012; 93(4):1154–60.
Moyssakis I, Tektonidou MG, Vasilliou VA, Samarkos M, Votteas V, Moutsopoulos HM. Libman-sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med. 2007;120(7):636–42.